Aktis Oncology director Ken Herrmann disposes of 3,065 common shares worth $77,279.54 - AKTS News | RalliesAktis Oncology director Ken Herrmann disposes of 3,065 common shares worth $77,279.54
A
AKTS• Director sells shares after exercising options
- Aktis Oncology director Ken Herrmann sold 3,065 common shares on July 17, 2026 at about $25.21 per share.
- He exercised stock options for 3,065 shares the same day at $0.08 per share.
- After the transaction, he reported 0 common shares owned directly.
